Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov;75(11):1432-1436.
doi: 10.1111/anae.15141. Epub 2020 Jun 15.

Understanding the COVID-19 coagulopathy spectrum

J Thachil  1 , S Agarwal  2
Affiliations
Editorial

Understanding the COVID-19 coagulopathy spectrum

J Thachil et al. Anaesthesia. 2020 Nov.
No abstract available

Keywords: COVID-19; coagulation; thrombosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antithrombotic management of COVID‐19 coagulopathy based on D‐dimers and platelet counts.
See this image and copyright information in PMC

References

    1. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID‐19. Journal of Infection 2020; 80: 607–13. - PMC - PubMed
    1. Zhang W, Zhao Y, Zhang F, et al. The use of anti‐inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID‐19): the perspectives of clinical immunologists from China. Clinical Immunology 2020; 214: 108393. - PMC - PubMed
    1. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients. Journal of Thrombosis and Haemostasis 2020; 18: 1743–46. - PMC - PubMed
    1. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis 2020; 18: 1094–9. - PMC - PubMed
    1. Klok FA, Kruipb MJHA, van der Meerc NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID‐19. Thrombosis Research 2020; 191: 145–47. - PMC - PubMed

Publication types

Substances